Literature DB >> 23578233

Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial.

Christopher C Parker1, Matthew R Sydes, Malcolm D Mason, Noel W Clarke, Daniel Aebersold, Johann S de Bono, David P Dearnaley, Alastair W S Ritchie, J Martin Russell, George Thalmann, Mahesh K B Parmar, Nicholas D James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23578233     DOI： 10.1111/bju.12087

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  14 in total

Review 1.  [Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis].

Authors:  A Spek; A Herlemann; C Gratzke; C G Stief
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

2.  Perioperative outcomes following radical prostatectomy for patients with disseminated cancer: An analysis of the National Surgical Quality Improvement Program database.

Authors:  Raj Satkunasivam; Christopher J D Wallis; James Byrne; Azik Hoffman; Douglas C Cheung; Girish S Kulkarni; Avery B Nathens; Robert K Nam
Journal:  Can Urol Assoc J       Date:  2016 Nov-Dec       Impact factor: 1.862

3.  Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.

Authors:  Mahesh Kb Parmar; Matthew R Sydes; Fay H Cafferty; Babak Choodari-Oskooei; Ruth E Langley; Louise Brown; Patrick Pj Phillips; Melissa R Spears; Sam Rowley; Richard Kaplan; Nicholas D James; Timothy Maughan; Nicholas Paton; Patrick J Royston
Journal:  Clin Trials       Date:  2017-08-22       Impact factor: 2.486

Review 4.  Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 5.  Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice.

Authors:  Dena R Cohen; Susan Todd; Walter M Gregory; Julia M Brown
Journal:  Trials       Date:  2015-04-22       Impact factor: 2.279

6.  Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome.

Authors:  Giulia Riva; Giulia Marvaso; Matteo Augugliaro; Dario Zerini; Cristiana Fodor; Gennaro Musi; Ottavio De Cobelli; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  Ecancermedicalscience       Date:  2017-11-30

7.  Characteristics and national trends of patients receiving treatment of the primary tumor for metastatic prostate cancer.

Authors:  Sumi Sinha; Vinayak Muralidhar; Felix Y Feng; Paul L Nguyen
Journal:  Prostate Int       Date:  2017-04-18

Review 8.  Palliative radiotherapy.

Authors:  Katie Spencer; Rhona Parrish; Rachael Barton; Ann Henry
Journal:  BMJ       Date:  2018-03-23

9.  Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?

Authors:  Yeona Cho; Jee Suk Chang; Koon Ho Rha; Sung Joon Hong; Young Deuk Choi; Won Sik Ham; Jun Won Kim; Jaeho Cho
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.

Authors:  Nicholas D James; Melissa R Spears; Noel W Clarke; David P Dearnaley; Malcolm D Mason; Christopher C Parker; Alastair W S Ritchie; J Martin Russell; Francesca Schiavone; Gerhardt Attard; Johann S de Bono; Alison Birtle; Daniel S Engeler; Tony Elliott; David Matheson; Joe O'Sullivan; Delia Pudney; Narayanan Srihari; Jan Wallace; Jim Barber; Isabel Syndikus; Mahesh K B Parmar; Matthew R Sydes
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.